RE:RE:RE:Canada marijuana firms say illegal rivals costing them custoYes lets talk about a valuation. Let's say you get lucky and revenue 12 Million a year. At a 300 million m/c value, your paying 25x SALES! Are you kidding me? Slightly overvalued? Landslide overvalued. That means, they have to sell 25x more, just to have a normal 1x sales valuation. Lets not even get into the EBITDA/Net valuation because your losing 3 Million a quarter. Plus with all new competition... Come on buddy, get real. If the company survives your light years away from this valuation even to be close to making sense. AND no one is to say the new ruling in 6 months wont keep and include the MMAR people, nice try.
endofdays7 wrote:
lol buddy allard ruling stated patients don't have enough access to medicine why because we don't have enough access to them. 6 months to overhall mmpr to improve access for patients. Shoppers making inquiries with lps. We're going into storefronts bottom line. No one cares if we are slightly overvalued based on current numbers. We are paying a slight premium to get in on the ground floor before expansion of the medical system and eventually legalization. Your arguments lack any practical foresight. Your shorting! At least raise points reletice to future growth. Oh wait you can't lol because as far as markets go it's hard to find a business with better odds for serious growth then canopy and a few other my plays.